Tyra Biosciences, Inc. IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Tyra Biosciences, Inc. | TYRA - NASDAQ |
$14.00-$16.00 | $16.00 | $29.90 | 10.8 million | 9/15/2021 |
| BofA Securities, Jefferies, Cowen | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Terms Added 2021-09-09 Filed 2021-08-20 Terms Changed 2021-09-14 | ||||||
Tyra Biosciences, Inc. Quote & Chart - Click for current quote - TYRA
IPO Boutique aggregates information on public companies and private companies, such as "TYRA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Tyra Biosciences, Inc. (adapted from Tyra Biosciences, Inc. prospectus):
They are a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "TYRA" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.